#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14442	16S	1529	1529	99.93	16S.l6.c4.ctg.1	1989	720.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1672	1672	T	788	T,C,G	692,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14442	16S	1529	1529	99.93	16S.l6.c4.ctg.1	1989	720.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	854	C,T	781,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27044	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3411	789.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1564	1564	A	878	A,G	799,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27044	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3411	789.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2198	2198	C	881	C,A	793,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27044	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3411	789.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2272	2272	A	874	A,G	807,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27044	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3411	789.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2824	2824	C	793	C	733	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	14	blaTEM	861	198	100.0	blaTEM.l15.c4.ctg.1	234	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2190	folP	855	855	99.88	folP.l15.c4.ctg.1	1563	139.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1011	1013	AGC	253;252;249	A;G;C	231;229;226	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5820	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3479	167.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	636	638	GCC	174;172;172	G;C,A;C	161;160,1;160	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5820	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3479	167.1	1	SNP	p	S91F	1	.	.	271	273	TTC	624	626	TTC	182;180;180	T;T,C;C	166;164,1;164	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1724	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1305	131.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	442	444	ACC	206;206;207	A,G;C;C	184,1;190;193	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1724	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1305	131.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	640	642	CAC	211;212;210	C;A;C	195;192;194	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1724	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1305	131.6	0	.	p	.	0	A127fs	FSHIFT	379	379	G	706	706	G	206	G	191	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1724	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1305	131.6	1	SNP	p	G45D	0	.	.	133	135	GGC	460	462	GGC	205;206;207	G;G;C,T	185;188;186,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	866	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	913	93.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5376	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2917	183.8	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1447	1449	GTC	208;207;204	G,A;T;C	181,1;181;179	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5376	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	D86N	0	.	.	256	258	GAC	553	555	GAC	236;235;236	G;A;C	212;205;212	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5376	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	R87W	0	.	.	259	261	CGT	556	558	CGT	236;235;238	C,A;G;T	211,1;211;210	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5376	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	S87R	1	.	.	259	261	CGT	556	558	CGT	236;235;238	C,A;G;T	211,1;211;210	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5376	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	R87I	0	.	.	259	261	CGT	556	558	CGT	236;235;238	C,A;G;T	211,1;211;210	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5376	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	S88P	0	.	.	262	264	TCC	559	561	TCC	236;236;240	T;C;C	210;214;217	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4496	parE	1986	1986	99.9	parE.l6.c30.ctg.1	2506	178.5	0	.	p	.	0	T169I	NONSYN	505	507	ACC	745	747	ATC	221;220;223	A;T;C	203;206;211	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4496	parE	1986	1986	99.9	parE.l6.c30.ctg.1	2506	178.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1468	1470	GGC	207;206;202	G;G;C	188;186;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1232	1234	GCA	255;255;255	G;C,T;A	224;221,1;225	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1235	1237	ATC	259;258;261	A;T;C	228;225;227	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1247	1249	GTG	253;252;251	G;T;G	226;221;223	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1247	1249	GTG	253;252;251	G;T;G	226;221;223	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1751	1753	ACC	222;223;223	A;C;C,T	202;205;206,1	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1805	1807	GCG	233;231;229	G;C;G	201;183;185	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1805	1807	GCG	233;231;229	G;C;G	201;183;185	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1928	1930	GGT	190;189;187	G;G;T	169;167;165	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1937	1939	GGC	189;187;185	G;G;C	169;167;162	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4298	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2437	175.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1955	1957	CCG	168;168;166	C,G;CG,CGG;G	122,3;113,1;123	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6116	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3203	190.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1679	1681	CCG	226;226;224	C;C;G,A	201;205;196,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2488	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1780	138.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	622	622	C	173	C	154	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	706	708	GGA	252;254;252	G;G;A	230;229;222	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	0	.	p	.	0	.	INDELS	629	630	AA	909	911	TAG	236;237;235	T;A;G,T	215;222;216,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	0	.	p	.	0	.	MULTIPLE	631	633	TAC	913	916	CAAT	235;234;235;234	C;A;A;T	222;223;223;222	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	0	.	p	.	0	N212fs	FSHIFT	634	634	A	918	918	T	234	T	223	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	1	SNP	p	G120K	0	.	.	358	360	GGT	637	639	GGT	239;238;235	G;G;T	218;217;214	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	1	SNP	p	A121D	0	.	.	361	363	GCC	640	642	GCC	236;236;236	G;C;C	216;217;217	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2956	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1465	200.1	1	SNP	p	A121N	0	.	.	361	363	GCC	640	642	GCC	236;236;236	G;C;C	216;217;217	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10678	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4835	220.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1870	1872	AAT	228;228;231	A;A;T	214;212;214	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1132	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	885	126.9	1	SNP	p	V57M	1	.	.	169	171	ATG	501	503	ATG	232;233;233	A;T;G	211;213;212	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	M177T	NONSYN	529	531	ATG	888	890	ACG	349;344;344	A;C,T;G	335;332,1;333	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	909	911	GAC	304;309;304	G;A,G;C	302;305,1;302	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	T190M	NONSYN	568	570	ACG	927	929	ATG	298;295;293	A;T;G	297;292;290	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	L194S	NONSYN	580	582	TTA	939	941	TCA	274;274;276	T;C;A	272;274;276	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	984	986	CAG	303;307;305	C;A;G	298;301;300	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1005	1007	CTT	289;290;294	C;T;T	285;287;291	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1026	1028	AGT	311;315;324	A;G;T	306;308;312	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1095	1097	CCG	490;493;495	C;C,T;G	458;458,1;458	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1197	1199	TCG	540;543;544	T,G;C;G,T	497,1;502;500,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1368	1370	AAA	283;276;267	A;A;A	267;262;255	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1371	1373	AAG	269;266;256	A;A;G	256;256;248	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1386	1388	CAC	233;231;231	C;A;C	229;218;228	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1425	1427	GAA	216;217;211	G;A;A	216;216;209	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1503	1505	ACG	131;129;131	A;C;G	130;127;129	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1554	1556	ATT	221;220;222	A;T;T	205;201;206	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1557	1559	AGT	222;222;223	A;G;T,C	204;205;203,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1596	1598	CTA	245;245;255	C;T;A	224;222;230	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1638	1640	AAT	151;153;155	A;A;T	148;149;152	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1707	1709	TCA	229;229;232	T;C;A	217;216;216	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1731	1733	ATG	247;248;248	A;T;G	234;234;237	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2025	2027	ACC	549;546;548	A;C;C	496;499;503	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9714	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2582	375.3	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2121	2123	GAA	574;569;569	G;A;A	529;525;524	.	Tetracycline resistance
